147 related articles for article (PubMed ID: 2997252)
1. Antibody-mediated extraction of the main tetrahydrocannabinol metabolite, 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid, from human urine and its identification by gas chromatography-mass spectrometry in the sub-nanogram range.
Lemm U; Tenczer J; Baudisch H; Krause W
J Chromatogr; 1985 Aug; 342(2):393-8. PubMed ID: 2997252
[No Abstract] [Full Text] [Related]
2. Detection and quantitation of urinary 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid, a metabolite of tetrahydrocannabinol, by capillary gas chromatography and electron impact mass fragmentography.
Paul BD; Mell LD; Mitchell JM; McKinley RM; Irving J
J Anal Toxicol; 1987; 11(1):1-5. PubMed ID: 3029505
[TBL] [Abstract][Full Text] [Related]
3. A semi-automated extraction and spotting system for drug analysis by TLC. I. Procedure for analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine.
Vinson JA; Lopatofsky DJ
J Anal Toxicol; 1985; 9(1):6-9. PubMed ID: 2984464
[TBL] [Abstract][Full Text] [Related]
4. [Routine detection of the THC metabolite 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in forensic practice].
Hanke M; Megges G
Z Rechtsmed; 1983; 90(2):105-8. PubMed ID: 6312709
[TBL] [Abstract][Full Text] [Related]
5. Gas chromatography-mass spectrometry-single ion monitoring measurement of 11-nor-delta 9-tetrahydrocannabinol-carboxylic acid in urine.
Boldis O; Kocsis G; Gachályi A; Furész J
J Chromatogr Sci; 2003 Apr; 41(4):190-4. PubMed ID: 12803806
[TBL] [Abstract][Full Text] [Related]
6. Solid-phase extraction of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid from human urine with gas chromatographic-mass spectrometric confirmation.
Dixit V; Dixit VM
J Chromatogr; 1991 Jun; 567(1):81-91. PubMed ID: 1655822
[TBL] [Abstract][Full Text] [Related]
7. Confirmation of a tetrahydrocannabinol metabolite in urine by gas chromatography.
Whiting JD; Manders WW
J Anal Toxicol; 1982; 6(1):49-52. PubMed ID: 6281576
[TBL] [Abstract][Full Text] [Related]
8. Rapid method for the GC/MS confirmation of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in urine.
Baker TS; Harry JV; Russell JW; Myers RL
J Anal Toxicol; 1984; 8(6):255-9. PubMed ID: 6097767
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment of urine samples for the analysis of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid using solid-phase extraction.
Parry RC; Nolan L; Shirey RE; Wachob GD; Gisch DJ
J Anal Toxicol; 1990; 14(1):39-44. PubMed ID: 2156110
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine. IV. A comparison of five methods.
Jones AB; ElSohly HN; Arafat ES; ElSohly MA
J Anal Toxicol; 1984; 8(6):249-51. PubMed ID: 6097765
[TBL] [Abstract][Full Text] [Related]
11. Analysis of urine for 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid using Sep-PAK cartridges for sample cleanup.
Nakamura GR; Stall WJ; Masters RG; Folen VA
Anal Chem; 1985 Jun; 57(7):1492-4. PubMed ID: 2994522
[No Abstract] [Full Text] [Related]
12. Analysis of 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in biological samples by gas chromatography tandem mass spectrometry (GC/MS-MS).
Chiarotti M; Costamagna L
Forensic Sci Int; 2000 Oct; 114(1):1-6. PubMed ID: 10924845
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of 11 -nor-delta9-tetrahydrocannabinol-9-carboxylic acid with GC-MS in urine collected for doping analysis.
De Cock KJ; Delbeke FT; De Boer D; Van Eenoo P; Roels K
J Anal Toxicol; 2003 Mar; 27(2):106-9. PubMed ID: 12670005
[TBL] [Abstract][Full Text] [Related]
14. Interference in GC/MS confirmation of delta-9-tetrahydrocannabinol-9-carboxylic acid by a secondary tetrahydrocannabinol metabolite.
Podkowik BI; Kippenberger DJ; Smith ML
Clin Chem; 1991 Jul; 37(7):1307-8. PubMed ID: 1649710
[No Abstract] [Full Text] [Related]
15. Analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine. III. A GC/ECD procedure.
ElSohly MA; Arafat ES; Jones AB
J Anal Toxicol; 1984; 8(1):7-9. PubMed ID: 6323853
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine. VI. Specificity of the assay with respect to indole carboxylic acids.
ElSohly MA; Jones AB; ElSohly HN; Stanford DF
J Anal Toxicol; 1985; 9(4):190-1. PubMed ID: 2993744
[No Abstract] [Full Text] [Related]
17. The analysis of delta9-tetrahydrocannabinol and metabolite in whole blood and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in urine using disposable pipette extraction with confirmation and quantification by gas chromatography-mass spectrometry.
Schroeder JL; Marinetti LJ; Smith RK; Brewer WE; Clelland BL; Morgan SL
J Anal Toxicol; 2008 Oct; 32(8):659-66. PubMed ID: 19007518
[TBL] [Abstract][Full Text] [Related]
18. Identification in human urine of delta 9-tetrahydrocannabinol-11-oic acid glucuronide: a tetrahydrocannabinol metabolite.
Williams PL; Moffat AC
J Pharm Pharmacol; 1980 Jul; 32(7):445-8. PubMed ID: 6105177
[TBL] [Abstract][Full Text] [Related]
19. [Detection of the metabolite of delta-9-tetrahydrocannabinol in urine by means of GC/MS and interpretation of analytical findings].
Balíková M; Maresová V
Soud Lek; 1996 Dec; 41(4):36-40. PubMed ID: 16841441
[TBL] [Abstract][Full Text] [Related]
20. Confirmation testing of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid in urine with micellar electrokinetic capillary chromatography.
Wernly P; Thormann W
J Chromatogr; 1992 Sep; 608(1-2):251-6. PubMed ID: 1331141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
